On Monday, CVS Health Corp (NYSE: CVS) was 0.49% up from the session before settling in for the closing price of $55.54. A 52-week range for CVS has been $52.77 – $83.25.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 13.36% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at -34.19%. With a float of $1.26 billion, this company’s outstanding shares have now reached $1.29 billion.
In an organization with 300000 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -3.51%, operating margin of 2.55%, and the pretax margin is 1.83%.
CVS Health Corp (CVS) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward CVS Health Corp stocks. The insider ownership of CVS Health Corp is 0.19%, while institutional ownership is 82.15%. The most recent insider transaction that took place on May 02 ’24, was worth 53,879. In this transaction Director of this company bought 1,000 shares at a rate of $53.88, taking the stock ownership to the 21,630 shares. Before that another transaction happened on May 02 ’24, when Company’s Director bought 9,181 for $54.49, making the entire transaction worth $500,294. This insider now owns 9,356 shares in total.
CVS Health Corp (CVS) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted 2.12 earnings per share (EPS) during the time that was better than consensus figure (set at 1.99) by 0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.4 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -34.19% per share during the next fiscal year.
CVS Health Corp (NYSE: CVS) Trading Performance Indicators
You can see what CVS Health Corp (CVS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.59. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.19. Likewise, its price to free cash flow for the trailing twelve months is 40.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 3.94, a number that is poised to hit 1.29 in the next quarter and is forecasted to reach 6.64 in one year’s time.
Technical Analysis of CVS Health Corp (CVS)
Let’s dig in a bit further. During the last 5-days, its volume was 17.55 million. That was better than the volume of 11.32 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 20.29%. Additionally, its Average True Range was 2.17.
During the past 100 days, CVS Health Corp’s (CVS) raw stochastic average was set at 11.12%, which indicates a significant decrease from 16.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.47% in the past 14 days, which was higher than the 35.31% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $59.51, while its 200-day Moving Average is $63.78. However, in the short run, CVS Health Corp’s stock first resistance to watch stands at $56.44. Second resistance stands at $57.07. The third major resistance level sits at $57.71. If the price goes on to break the first support level at $55.17, it is likely to go to the next support level at $54.53. Assuming the price breaks the second support level, the third support level stands at $53.90.
CVS Health Corp (NYSE: CVS) Key Stats
There are 1,258,408K outstanding shares of the company, which has a market capitalization of 68.35 billion. As of now, sales total 357,776 M while income totals 8,344 M. Its latest quarter income was 91,234 M while its last quarter net income were 1,770 M.
